跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM THIOSULFATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM THIOSULFATE INJECTION USP
Authorized
STANDARD
SODIUM THIOSULFATE INJECTION USP
HOPE PHARMACEUTICALS LTD
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ba394fe03fbfdd96
Company
HOPE PHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
ba394fe03fbfdd96
Drug Approval Canada Name
SODIUM THIOSULFATE INJECTION USP
Product Name
SODIUM THIOSULFATE INJECTION USP
Status
Marketed
Status Date
2015-11-23
Original Market Date
2015-11-23
Din
02428393
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
91:04.12
Atc Original
V03AB06 THIOSULPHATE
Atc Name
v 03 ab 06
Aig Number
0109248001
Company Name
HOPE PHARMACEUTICALS LTD
Company Address
170, 422 Richards Street, Vancouver, British Columbia, Canada, V6B 2Z4
Company Detail Path
/organization/hope-pharmaceuticals-ltd
Company Information
Pharmaceutical Company Name
HOPE PHARMACEUTICALS LTD
Country Name
Israel
Province Name
Central District
City Name
tel aviv-jaffa,central district,country_il
Address
6 Itzhak Sade
Active Ingredients
SODIUM THIOSULFATE
250 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ba394fe03fbfdd96
Type
Standard
Back to Health Canada Approvals